TEDCO Invests in ICaPath
ICaPath is a Baltimore-based biotech company that has developed a cancer immunotherapy product using encapsulated IL-12 in PLGA nanoparticles. ICaPath's proprietary technologies for PLGA nanoparticle encapsulation can be expanded to additional payload as well.